EPO grants patent for Autonomix Medical’s catheter technology
After identifying the targeted nerves, the company’s radiofrequency ablation technology is employed to ablate the nerves. Credit: MAD.vertise / Shutterstock.com....
Autonomix
Autonomix Medical, Inc. Technology and Early
THE WOODLANDS, TX, April 24, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device...
Autonomix Medical, Inc. Granted U.S. Patent Covering
Continued progress with growing global patent portfolio to over 80 issued patents and 40 pending patent applications Proprietary sensing and...
Autonomix Medical, Inc. Announces U.S. Patent Granted
Growing global patent portfolio to over 120 patents with 80 issued patents and over 40 pending patent applications Previously completed...
